Biotechnology · Boston, MA · Founded 2018 · In IPO Registration
Operator of a biotechnology company intended to develop immunomodulators and oncology drugs. Odyssey Therapeutics is based in Boston, MA and was founded in 2018. It is valued at about $638 million as of Oct 2026, set by institutional fund marks. It has raised $716 million across 4 recorded rounds; the latest was a $214 million later-stage round in Jun 2025.
PMV mark · valuation
$638.2M
Oct 2026
Priced at
—
Total raised
$716.2M
Last round
Later Stage VC
Jun 2025
Team — not yet on record
No current team members for Odyssey Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Odyssey Therapeutics with a free account
·The complete investor list: 32 names
·Watch Odyssey Therapeutics: the Monday email on marks, rounds and moves
